FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1142-1144 October 10, 1996 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

In this issue of the Journal three important articles appear, with major implications for the clinical management of infection with the human immunodeficiency virus (HIV).^1,2,3 Hammer et al.¹ and Katzenstein et al.² describe the clinical and virologic results of the AIDS Clinical Trials Group Study 175 (ACTG 175), a large trial involving more than 2400 HIV-infected persons with CD4 cell counts from 200 to 500 cells per cubic millimeter. This trial clearly shows that antiretroviral therapy in such patients delays the progression of disease to AIDS and reduces mortality. Didanosine alone and the combination of zidovudine with didanosine or with . . . [Full Text of this Article]

References

Related Letters:

Viral Load and Combination Therapy for Human Immunodeficiency Virus
Phillips A. N., Smith G. D., Feder H. M., Milch L. R., Srinivasan V., Beidas S. O., Corey L., Holmes K. K., Katzenstein D., The AIDS Clinical Trials Group , Study 175 Investigators
Extract | Full Text  
N Engl J Med 1997; 336:958-961, Mar 27, 1997. Correspondence

This article has been cited by other articles:

• Levine, A. M., Seneviratne, L., Espina, B. M., Wohl, A. R., Tulpule, A., Nathwani, B. N., Gill, P. S. (2000). Evolving characteristics of AIDS-related lymphoma. Blood 96: 4084-4090 [Abstract] [Full Text]  
• Phillips, A. N., Smith, G. D., Feder, H. M., Milch, L. R., Srinivasan, V., Beidas, S. O., Corey, L., Holmes, K. K., Katzenstein, D., The AIDS Clinical Trials Group, , Study 175 Investigators, (1997). Viral Load and Combination Therapy for Human Immunodeficiency Virus. NEJM 336: 958-961 [Full Text]  
• (1996). Patterns Emerge from ACGT 175, Delta, and CPCRA 007. AIDS Clin Care 1996: 3-3 [Full Text]